Prescription Drugs-B - Betaxolol Hcl - Betaxolol Hcl 0.5% Drops 1X5 ml By Falcon Pharm

Betaxolol Hcl 0.5% Drops 1X5 ml By Falcon Pharm

Betaxolol Hcl 0.5% Drops 1X5 ml By Falcon Pharm Item No.:This Item Requires A Valid Order From A Physician Licensed in USA. RXD2963619 Betaxolol Hcl 0.5% Drops 1X5 ml Mfg.By: Falcon Pharm USA. This Item Requires A Valid Order From A Physician Licensed in The USA. Item No.:RXD2963619 NDC No./Upcno.: 61314-0245-01 Category: Betaxolol Hcl Compare To: Betoptic
UPC No.: 361314245014 Mfg.Item No.:024501

$ 48.99
PLEASE PROVIDE US THE NAME, ADDRESS, PHONE #, FAX #, STATE LIC.#, NAME OF STATE, DEA#,AND NPI# OF ORDERING PHYSICIAN. PLEASE PROVIDE ALL INFORMATION AVAILABLE AND ASK YOUR PHYSICIAN TO FAX US THE PRESCRIPTION AT 760-344-6321 FOR THE QUANTITY.
Quantity:

Compares to BETOPTIC® & Kerlone®

DESCRIPTION

Betaxolol Hydrochloride Ophthalmic Solution contains betaxolol hydrochloride, a cardioselective beta-adrenergic receptor blocking agent, in a sterile isotonic solution. Betaxolol hydrochloride is a white, crystalline powder, soluble in water, with a molecular weight of 343.89.

Each mL of Betaxolol Hydrochloride Ophthalmic Solution (0.5%) contains: Active: 5.6 mg betaxolol hydrochloride equivalent to betaxolol base 5 mg. Preservative: Benzalkonium Chloride 0.1%. Inactives: Edetate Disodium, Sodium Chloride, Hydrochloric Acid and/or Sodium Hydroxide (to adjust pH), and Purified Water.

INDICATIONS

Betaxolol Hydrochloride Ophthalmic Solution has been shown to be effective in lowering intraocular pressure and is indicated in the treatment of ocular hypertension and chronic open-angle glaucoma. It may be used alone or in combination with other anti-glaucoma drugs.

In clinical studies Betaxolol Hydrochloride Ophthalmic Solution was safely used to lower intraocular pressure in 47 patients with both glaucoma and reactive airway disease who were followed for a mean period of 15 months. However, caution should be used in treating patients with severe reactive airway disease or a history of asthma.

DOSAGE AND ADMINISTRATION

The recommended dose is one to two drops of Betaxolol Hydrochloride Ophthalmic Solution in the affected eye(s) twice daily. In some patients, the intraocular pressure lowering responses to Betaxolol Hydrochloride Ophthalmic Solution may require a few weeks to stabilize. As with any new medication, careful monitoring of patients is advised.

If the intraocular pressure of the patients is not adequately controlled on this regimen, concomitant therapy with pilocarpine and other miotics, and/or epinephrine and/or carbonic anhydrase inhibitors can be instituted.

SIDE EFFECTS

The following adverse reactions have been reported in clinical trials with Betaxolol Hydrochloride Ophthalmic Solution.

Ocular: Discomfort of short duration was experienced by one in four patients, but none discontinued therapy occasional tearing has been reported. Rare instances of decreased corneal sensitivity, erythema, itching sensation, corneal punctate staining, keratitis, anisocoria, edema, and photophobia have been reported.

Additional medical events reported with other formulations of betaxolol include blurred vision, foreign body sensation, dryness of the eyes, inflammation, discharge, ocular pain, decreased visual acuity, and crusty lashes.

Systemic: Systemic reactions following administration of Betaxolol Hydrochloride Ophthalmic Solution 0.5% or Betaxolol Hydrochloride Ophthalmic Suspension 0.25% have been rarely reported. These include:

Cardiovascular: Bradycardia, heart block and congestive failure.

Pulmonary: Pulmonary distress characterized by dyspnea, bronchospasm, thickened bronchial secretions, asthma and respiratory failure.

Central Nervous System: Insomnia, dizziness, vertigo, headaches, depression, lethargy, and increase in signs and symptoms of myasthenia gravis.

Other: Hives, toxic epidermal necrolysis, hair loss and glossitis.

FREE

shipping*

FREE

gifts

FREE

samples

GET

5% OFF

Click here for Prescribing Information